+91 7069 000 000 | +91 79 2771 2771 | +91 98250 66664 | +91 98250 66668 info@cims.org

List of Publications

List of Publications

Sr NoTitleJournal
1.Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside, in combination

J Am Coll Cardiol 2003;41(6 Suppl. A):561-568

2.Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside in combination

J Am Coll Cardiol 2003;41(6 Suppl. A):1101-201.

3.Beneficial effects of distal protection device in Reducing the use of intracoronary vasodilators And glycoprotein IIb/IIIa receptor antagonists. During percutaneous coronary interventions.

Catheterization and Cardiovascular Interventions 2004; 62: pg 90. (Abstract)

4.Improvement in mace by sequential administration Of boluses of intracoronary adenosine and sodium. Nitroprusside during percutaneous coronary Interventions .

Catheterization and Cardiovascular Interventions 2004; 62:130-131

5.Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study

Indian J Pharmacol 2005; 37:13-17.

6First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry.

Eur Heart J 2006;27(suppl 1): 827-985

7.First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals

Eur Heart J 2006;27(suppl 1): 291-565.

8.Effect of Metoprolol CR/XL on Exercise Capacity and Subsequent Variation in Pulmonary Artery Pressure in Heart Failure Patients Using an Innovative Implant Involving Acoustic Telemetry.

Eur Heart J 2006;27(suppl 1): 827-985

9.First In Man Non-Invasive Monitoring of Pulmonary Artery Pressure from an Implantable Device Using Acoustic Telemetry: A One Year Follow-Up Data

Eur Heart J 2006;27(suppl 1): 1-290

10.Measuring Pulmonary Artery Pressure Non-invasively with Conventional Contrast Echocardiography in Congestive Heart Failure.

Eur Heart J 2006;27(suppl 1): 1-290

11.First-in-man: Coronary Sinus Narrowing with a Reducer Stent- A Possible Alternative Percutaneous Treatment for Patients with Refractory Angina

J Am Coll Cardiol 2006;47;1B-56B

12.First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication.

J Am Coll Cardiol 2006;47;1B-56B.

13.Intraconory Boluses of Adenosine and Sodium Nirtoprusside in combination Reverses Slow/No Reflow During Angioplasty: A Clinical Scenario of Experimental Pre-conditioning.

J Am Coll Cardiol 2006;47:381A-384A

14.Wireless Acoustic Communication With a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients With Congestive Heart Failure

J Am Coll Cardiol 2007;49:784 – 789

15.Coronary Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris: A prospective, open label, multi-center safety feasibility first-in-man study.

J Am Coll Cardiol 2007;49:1783-1789.

16Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.

Can J Physiol Pharmacol 2007;85 (3-4):476-82.

17.Systemic Primary Aspiration in Acute Myocardial Percutaneous Intervention: A Multicentre Randomized controlled trial of the export aspiration catheter.

Euro Intervention 2008;4:222-228

18.Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity

Indian Heart J 2009;61:34-9

19.Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience

EuroIntervention 2009;5:206-211

20.Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice: Extended 12-Month data from the E-Five Registry

JACC Cardiovasc Interv 2009;2(12):1227-35

21.Platelet Inhibition with Cangrelor in Patients Undergoing PCI

N Engl J Med 2009;361:2318-29.

22.Rationale and design of the Patient Related Outcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

Am Heart J 2009;158:902-909.e5

23.Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial (TRUST – 2)

J Heart Lung Transplant 2010;29(2):137-49

24.Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Circulation 2010;122:1056-1067

25.Pre Treatment with thienopyridines reduces the amount of Myonecrosis in acute coronary syndrome patients invasively managed: insights from the champions trials.

Circulation 2010;122:A14183

26Long-Term Follow-Up to Evaluate the Safety of the Neovasc Reducer a Device-Based Therapy for Chronic Refractory Angina.

J Am Coll Cardiol 2010;55;A98.E927

27.Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial).

J Am Coll Cardiol 2011;58:B172-B173

28.Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions – A Single Center Experience.

J Am Coll Cardiol 2011;58:B174